[Pharm-policy] letter to Dr. Novotny regarding empirical basis for trade policy

[James Love]

A few persons have written to point out a careless error in the letter
to Dr. Novotny.  In the discussion of the time between filing for a
patent and FDA marketing approval, I should have stated that the 4.4
years for HIV/AIDS drugs was far "shorter" than the time assumed in the
Tufts study, rather than longer.  

  Jamie


-- 
James Love
http://www.cptech.org
mailto:love@cptech.org
voice 1.202.387.8030